Adage Capital Partners Gp, L.L.C. Horizon Therapeutics Public LTD CO Transaction History

Adage Capital Partners Gp, L.L.C.

$51 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $5.74 Million - $6.71 Million	-57,973 Reduced 1.94%	2,936,633 $340 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $42 Million - $49 Million	435,694 Added 17.03%	2,994,606 $308 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $109 Million - $115 Million	1,015,212 Added 65.76%	2,558,912 $279 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $33.5 Million - $61.2 Million	537,457 Added 53.41%	1,543,700 $176 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $52.4 Million - $75.2 Million	888,743 Added 756.38%	1,006,243 $62.3 Million

Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $20.8 Million - $30.5 Million	-262,500 Reduced 69.08%	117,500 $9.37 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $19.9 Million - $25.3 Million	230,000 Added 153.33%	380,000 $40 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $173 Million - $210 Million	-1,755,000 Reduced 92.13%	150,000 $16.2 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $31.7 Million - $38.1 Million	-345,000 Reduced 15.33%	1,905,000 $209 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $56.1 Million - $62.3 Million	650,000 Added 40.63%	2,250,000 $211 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $61.1 Million - $81.2 Million	-850,000 Reduced 34.69%	1,600,000 $147 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $83.1 Million - $105 Million	-1,240,772 Reduced 33.62%	2,450,000 $179 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $24 Million - $34.8 Million	434,823 Added 13.35%	3,690,772 $287 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $98.3 Million - $186 Million	3,255,949 New	3,255,949 $181 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $24.9 Million - $38.6 Million	-1,000,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $12.7 Million - $18.3 Million	-500,000 Reduced 33.33%	1,000,000 $36.2 Million
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $2.3 Million - $2.8 Million	100,000 Added 7.14%	1,500,000 $40.8 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $31.9 Million - $39.9 Million	1,400,000 New	1,400,000 $33.7 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account